World Diabetes Day – Looking Beyond Glucose
Every November 14th, the global community comes together to recognize World Diabetes Day—an opportunity to focus on transforming the lives of millions of people living
Onalabs, Member of the New DTX Consortium to Drive Adoption of Digital Therapies in Spain
Onalabs, a member of the new DTX Consortium, is working to drive the adoption of digital therapies in Spain.
On November 29th, Xavi Muñoz participated in the official presentation of the DTX Consortium. This is a public-private alliance formed by prominent representatives from the healthcare ecosystem, with the aim of promoting regulation and speeding up the time-to-market for digital therapies in Spain.
The consortium includes major pharmaceutical companies such as Angelini Pharma, Bayer, Boehringer Ingelheim, Ferrer, Merck, and Pfizer, as well as other large companies in the digital health sector like Teladoc Health, and a small number of startups, including Onalabs.
This presents a great opportunity to strengthen corporate and business ties, positioning Onalabs as a key company in the national healthcare ecosystem.
Here is the link to the press release.
Other Entries
Introducing Project ONALABS ATHLETES: Empowering the Next Generation of Cyclists and Runners
At Onalabs Inno-Hub, we’re thrilled to announce the launch of Project ONALABS ATHLETES, an exciting new initiative supporting 10 promising cyclists (road, mountain, and track)
Expanding the Boundaries of Digital Health: Our Collaboration with Atlas Medical
At Onalabs Inno-Hub, we are excited to announce our collaboration with Atlas Medical, a strategic alliance that strengthens our commitment to innovation in digital health.
